NewGenIvf Group Shares Set to Reverse Split on Monday, October 12th (NASDAQ:NIVF)

by · The Markets Daily

NewGenIvf Group Limited (NASDAQ:NIVF – Free Report) shares are scheduled to reverse split on the morning of Monday, October 12th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 11th.

NewGenIvf Group Stock Performance

Shares of NIVF stock traded down $0.02 on Thursday, reaching $0.08. The company had a trading volume of 18,737,952 shares, compared to its average volume of 75,441,272. The company has a 50-day moving average of $1.12 and a 200-day moving average of $6.93. NewGenIvf Group has a 12 month low of $0.06 and a 12 month high of $1,539.00.

NewGenIvf Group (NASDAQ:NIVF – Get Free Report) last issued its quarterly earnings data on Wednesday, October 7th. The company reported ($13.32) EPS for the quarter. The company had revenue of $0.96 million during the quarter. As a group, sell-side analysts expect that NewGenIvf Group will post 42.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday, July 24th. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, NewGenIvf Group currently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on NewGenIvf Group

Insider Buying and Selling at NewGenIvf Group

In other NewGenIvf Group news, Director Kong Yiu Cheung acquired 2,500,000 shares of the business’s stock in a transaction dated Monday, July 27th. The shares were acquired at an average price of $1.00 per share, with a total value of $2,500,000.00. Following the completion of the transaction, the director directly owned 3,722,223 shares in the company, valued at $3,722,223. This trade represents a 204.55% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 31.80% of the stock is owned by corporate insiders.

NewGenIvf Group Company Profile

(Get Free Report)

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing.

See Also